Ameriprise Financial Inc Anixa Biosciences Inc Transaction History

Ameriprise Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.1 $31,619 - $50,839	-12,400 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.88 - $5.5 $6,624 - $12,650	-2,300 Reduced 15.65%	12,400 $37,000
Q3 2021 Nov 15, 2021	BUY	$3.57 - $5.6 $15,351 - $24,080	4,300 Added 41.35%	14,700 $70,000
Q2 2021 Aug 16, 2021	BUY	$3.46 - $4.92 $35,984 - $51,168	10,400 New	10,400 $40,000

5.48M

24.5K

23.4K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $81.9M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.